GES Monthly Newsletter, Quarter 3 (July – September) 2024

Corporate Strategy Update In Q3, we closed a Capital Raise for our expansion plans that includes a strategic pathway to maturing into a general pharmaceutical manufacturer: We are excited to share the progress around the developments towards the end of the year. New Members We have continued our growth, and as of September 2024, we […]
Exciting Upgrades at GESLabs: Elevating Manufacturing Capacities for Enhanced Partner Value

The conclusion of our dedicated 18-month optimization program has resulted in a significant reduction to our manufacturing cost base….which means better value for our partners! Enhancements for Unmatched Quality and Efficiency Over the past 18 months, our dedicated team of engineers has focused on optimizing and modernizing our South African facility. These advancements, now fully […]
GES Monthly Newsletter, April 2024

April 2024 We are delighted by the progressive expansion of our enterprise and the sustained trajectory of strategic recruitment we have embarked upon. In pursuit of further advancement, we announce the appointment of Mr. Mark Gething as our new Managing Director. Mr. Gething, who commenced his tenure earlier this year, brings to our organization two […]
GES Monthly Newsletter, January 2024

GES is excited to start the year with a bolstered product catalog with new products entering our approach offering to our clients (please download our latest product catalog here). We have already firmed up supply relationships, particularly in Australia, Germany, and the UK. Our new offering for 2024 will be launching throughout Q2 of 2024 […]